ARIAD Pharmaceuticals, Inc. - Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA) Arqule, Inc. - Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL) Draxis Health Inc. - Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, Québec. [English, French and Spanish] Exelixis, Inc. - Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL) Genaera Corp. - Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR) ImmunoGen, Inc. - Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN) Dendreon Corp. - Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN) Heal Corporation - Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.